Showing results (191-200 of 214) with videos related to

Sort By:
Pageof 22
The Journal of Clinical Investigation|March 14, 2017
RANKL coordinates multiple osteoclastogenic pathways by regulating expression of ubiquitin ligase RNF146Yoshinori Matsumoto, Jose Larose, Oliver A Kent, et al.
ACS Central Science|July 29, 2024
DCAF16-Based Covalent Handle for the Rational Design of Monovalent DegradersMelissa Lim, Thang Do Cong, Lauren M Orr, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|August 20, 2024
Enhanced Type 1 Interferon Signature in Axial Spondyloarthritis Patients Unresponsive to Secukinumab TreatmentAddison Pacheco, Sinead Maguire, Zoya Qaiyum, et al.
The Journal of Clinical Investigation|July 9, 2024
A fibroblast-dependent TGF-β1/sFRP2 noncanonical Wnt signaling axis promotes epithelial metaplasia in idiopathic pulmonary fibrosisMax L Cohen, Alexis N Brumwell, Tsung Che Ho, et al.
ACS Central Science|July 29, 2025
DCAF16-Based Covalent Degradative Handles for the Modular Design of DegradersLauren M Orr, Sydney J Tomlinson, Hannah R Grupe, et al.
Annals of the Rheumatic Diseases|August 2, 2023
Proteomic and genomic profiling of plasma exosomes from patients with ankylosing spondylitisFataneh Tavasolian, Starlee Lively, Chiara Pastrello, et al.
Plos One|July 2, 2015
EMX2 Is a Predictive Marker for Adjuvant Chemotherapy in Lung Squamous Cell CarcinomasDongsheng Yue, Hui Li, Juanjuan Che, et al.
Frontiers in Genetics|March 28, 2015
Genetic variation in the functional ENG allele inherited from the non-affected parent associates with presence of pulmonary arteriovenous malformation in hereditary hemorrhagic telangiectasia 1 (HHT1) and may influence expression of PTPN14Tom G W Letteboer, Michael Benzinou, Christopher B Merrick, et al.
Cancer Cell|July 18, 2006
Targeting ADAM-mediated ligand cleavage to inhibit HER3 and EGFR pathways in non-small cell lung cancerBin-Bing S Zhou, Michael Peyton, Biao He, et al.
Cell Reports|April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancerCollin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
Pageof 22